We hypothesized that type 1 diabetes patients receiving this current standard of care and carrying a copy of the protective INS variant have a further reduced risk of developing diabetes complications compared to patients only carrying the susceptible INS variant. The gene discussed is INS; the disease is type 1 diabetes mellitus.